Details for New Drug Application (NDA): 215001
✉ Email this page to a colleague
NDA 215001 describes LOPERAMIDE HYDROCHLORIDE, which is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, Chartwell Rx, Edenbridge Pharms, Jubilant Cadista, Mylan, Roxane, Rubicon, Strides Pharma, Teva, Zydus Lifesciences, Allied, Alpharma Us Pharms, Duramed Pharms Barr, Perrigo, Sciegen Pharms Inc, Watson Labs, Wockhardt Bio Ag, Perrigo R And D, Able, Aurobindo Pharma, Contract Pharmacal, L Perrigo Co, LNK, Ohm Labs, Granules, Guardian Drug, Hetero Labs Ltd V, and Sun Pharm Inds Ltd, and is included in thirty-seven NDAs. It is available from one hundred and four suppliers. Additional details are available on the LOPERAMIDE HYDROCHLORIDE profile page.
The generic ingredient in LOPERAMIDE HYDROCHLORIDE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
The generic ingredient in LOPERAMIDE HYDROCHLORIDE is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
Summary for 215001
| Tradename: | LOPERAMIDE HYDROCHLORIDE |
| Applicant: | Edenbridge Pharms |
| Ingredient: | loperamide hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 215001
| Mechanism of Action | Opioid Agonists |
Medical Subject Heading (MeSH) Categories for 215001
Suppliers and Packaging for NDA: 215001
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LOPERAMIDE HYDROCHLORIDE | loperamide hydrochloride | CAPSULE;ORAL | 215001 | ANDA | Edenbridge Pharmaceuticals LLC. | 42799-605 | 42799-605-01 | 100 CAPSULE in 1 BOTTLE (42799-605-01) |
| LOPERAMIDE HYDROCHLORIDE | loperamide hydrochloride | CAPSULE;ORAL | 215001 | ANDA | Edenbridge Pharmaceuticals LLC. | 42799-605 | 42799-605-02 | 500 CAPSULE in 1 BOTTLE (42799-605-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 2MG | ||||
| Approval Date: | Oct 6, 2021 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
